Natixis bulks up research and consulting team
Natixis Global Asset Management has made four hires to its portfolio research and consulting group.
United Kingdom
-
-
enhance hires Canaccord manager hardisty
Barry Hardisty joined Enhance, an investment oversight services provider in the fiduciary sector, as director last week.
-
walker crips aum rise 28pc year on year
In its interim management statement the firm said it recorded a 28% rise in in discretionary and advisory assets.
-
Legg Mason Global Funds replaces a director
Legg Mason Global Funds director John Alldis has resigned from the company’s board for undisclosed business reasons.
-
Dividend growth an income divining rod
Dividend growth is a key factor, it is one of the drivers of share price performance argues AXA’s Jamie Forbes Wilson
-
UK macro puzzle likely to leave investors stumped
The release of inflation and wage growth figures over the past couple of days and the mixed reaction to them have added to an increasingly complex macro picture in the United Kingdom and made it more difficult for investors to make accurate calls on future numbers and policy decisions.
-
tony yousefian leaves charteris after three months
The manager of the £9m OPM Property Fund has exited the firm.
-
exjpmam bond manager joins smith williamson
John Anderson joins the fixed income team as partner to manage the Fixed Interest Trust.
-
Threadneedle appoints new board member
Threadneedle Investments has appointed Ann Roughead to its board and the board of Threadneedle Investment Services, as a non-executive director.
-
Inflation spike cranks up pressure on Carney
A surprisingly large rise in inflation has increased pressure on Mark Carney and the Bank of Englands monetary policy committee as they continue to walk a rate rise tightrope.
-
UK commercial property values rise at fastest
Commercial property values in the UK rose by 1.6% in June, up sharply from a 1.1% rise in May.
-
Asset managers could be set to cash in on Shire
Asset managers could be close to realising significant profits on shares held in pharmaceutical company Shire after its board finally agreed to deal talks with US suitor AbbVie.
